Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
749247-06-1
866889-02-3
1347750-82-6
1446282-39-8
1347750-77-9
1398044-50-2
13925-07-0 | Pyrazine, 2-ethyl-3,5-dimethyl- | AA00HVER | MFCD00047392
1403766-49-3 | tert-Butyl 3-hydroxy-3-(hydroxymethyl)piperidine-1-carboxylate | AA00HVQQ | MFCD23106337
1417789-50-4 | (3aS,6aS)-1-methyl-hexahydropyrrolo[3,4-b]pyrrole DiHCl | AA00HW5H | MFCD11656765
14255-39-1 | 6-Methyl-4-oxo-4h-pyran-2-carboxylic acid | AA00HWFR | MFCD00128539
1432571-98-6 | 4,4,5,5-Tetramethyl-2-(4-(1,1,1-trifluoro-2-methylpropan-2-yl)phenyl)-1,3,2-dioxaborolane | AA00HWRM | MFCD28134483
1445948-16-2 | 5-Bromo-8-chloro-1,2,3,4-tetrahydroisoquinoline | AA00HX0P | MFCD21706112
1450633-71-2 | cis-3-Methylpiperidine-2-carboxamide | AA00HX9Y | MFCD28385189
1479273-05-6 | 2-amino-1,3-benzoxazole-5-sulfonamide | AA00HXIP | MFCD27936866
1510778-85-4 | Potassium 2,2,2-trifluoroethane-2-trifluoroborate | AA00HXRK | MFCD27981361
1523617-99-3 | (1-Methyl-3-oxo-cyclobutyl)carbamic acid tert-butyl ester | AA00HXY9 | MFCD27986945